A female doctor explains a procedure to a patient
A female doctor explains a procedure to a patient

Anti-Infective

Explore our product portfolio.

5 ml bottle of Bausch + Lomb Besivance® Opthalmic Suspension 0.5%
5 ml bottle of Bausch + Lomb Besivance® Opthalmic Suspension 0.5%

BESIVANCE®

(besifloxacin ophthalmic suspension) 0.6%

5 ml bottle of Bausch + Lomb Zylet® Opthalmic Solution 0.5%
5 ml bottle of Bausch + Lomb Zylet® Opthalmic Solution 0.5%

ZYLET®

(loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension)

BESIVANCE®
IMPORTANT SAFETY INFORMATION

  • To avoid contamination of the bottle tip, do not touch the bottle tip with material from your eye, your fingers or other source. Wash hands thoroughly before using BESIVANCE®.
  • Do not wear contact lenses while using BESIVANCE® or any time you have signs or symptoms of an eye infection.
  • Before each use, turn the BESIVANCE® bottle upside down and shake once. While upside down, remove cap, tilt head back and gently squeeze bottle to put in one drop into the affected eye(s).
  • The most common side effect reported in clinical studies was eye redness in approximately 2% of patients. Other side effects reported in approximately 1-2% of patients were blurred vision, eye pain, eye irritation, itchy eye and headache.
  • Safety and effectiveness in infants below one year of age have not been established.
  • Not for injection into the eye.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please click here for full Prescribing Information for BESIVANCE®.

ZYLET®
IMPORTANT SAFETY INFORMATION

  • Do not use ZYLET® if you have eye infections caused by: most types of viruses; bacteria known as mycobacteria; or fungus.
  • ZYLET® contains a medicine known as a corticosteroid. Using corticosteroids for a long period of time may result in glaucoma and impaired vision. If you use ZYLET® for 10 days or longer, your doctor may monitor pressure in your eye.
  • Use of corticosteroids may result in cataract formation.
  • Use of steroids (corticosteroids) after cataract surgery may delay healing and increase bleb formation (a type of lesion on the eye).
  • Use of corticosteroids may increase the chance, or the severity, of an infection in your eye, or it may hide an eye infection. If your eye symptoms do not improve after 2 days of taking ZYLET®, contact your doctor for an examination.
  • The most common adverse reactions were eye redness, superficial punctate keratitis (a specific type of eye surface irritation), increased pressure in the eye, and burning and stinging when putting ZYLET® drops in the eye.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please click here for full Prescribing Information for ZYLET®.